Cetera Investment Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$253M Buy
1,034,600
+10,644
+1% +$2.48M 0.27% 65
2025
Q4
$212M Buy
1,023,956
+68,118
+7% +$13.5M 0.23% 81
2025
Q3
$177M Buy
955,838
+241,415
+34% +$41.4M 0.21% 91
2025
Q2
$109M Buy
714,423
+5,450
+0.8% +$838K 0.18% 104
2025
Q1
$118M Buy
708,973
+52,988
+8% +$8.29M 0.23% 90
2024
Q4
$94.9M Buy
655,985
+11,459
+2% +$1.78M 0.2% 98
2024
Q3
$104M Sell
644,526
-7,504
-1% -$1.2M 0.23% 87
2024
Q2
$95.3M Sell
652,030
-55,243
-8% -$8.22M 0.22% 89
2024
Q1
$112M Buy
707,273
+488,955
+224% +$77.8M 0.26% 73
2023
Q4
$34.2M Sell
218,318
-3,405
-2% -$522K 0.28% 68
2023
Q3
$34.5M Sell
221,723
-2,422
-1% -$400K 0.3% 60
2023
Q2
$37.1M Sell
224,145
-882
-0.4% -$142K 0.31% 54
2023
Q1
$34.9M Buy
225,027
+5,587
+3% +$902K 0.3% 51
2022
Q4
$38.8M Buy
219,440
+71,737
+49% +$12.4M 0.36% 47
2022
Q3
$24.1M Sell
147,703
-38,163
-21% -$6.46M 0.48% 29
2022
Q2
$33M Buy
185,866
+20,224
+12% +$3.6M 0.52% 30
2022
Q1
$29.4M Buy
165,642
+4,020
+2% +$684K 0.42% 39
2021
Q4
$27.6M Buy
161,622
+3,287
+2% +$538K 0.4% 46
2021
Q3
$25.6M Buy
158,335
+909
+0.6% +$155K 0.41% 43
2021
Q2
$25.9M Buy
157,426
+13,366
+9% +$2.21M 0.42% 41
2021
Q1
$23.7M Sell
144,060
-4,487
-3% -$726K 0.47% 39
2020
Q4
$23.4M Buy
148,547
+106,404
+252% +$15.7M 0.46% 37
2020
Q3
$6.27M Buy
42,143
+2,901
+7% +$429K 0.51% 38
2020
Q2
$5.52M Buy
39,242
+3,522
+10% +$513K 0.51% 40
2020
Q1
$4.68M Buy
35,720
+2,071
+6% +$294K 0.57% 39
2019
Q4
$4.91M Buy
33,649
+1,025
+3% +$139K 0.49% 50
2019
Q3
$4.22M Sell
32,624
-1,166
-3% -$154K 0.51% 47
2019
Q2
$4.71M Buy
33,790
+1,580
+5% +$219K 0.61% 35
2019
Q1
$4.5M Buy
32,210
+152
+0.5% +$20.4K 0.64% 35
2018
Q4
$4.13M Sell
32,058
-2,969
-8% -$414K 0.67% 32
2018
Q3
$4.84M Buy
35,027
+1,949
+6% +$259K 0.7% 27
2018
Q2
$4.01M Sell
33,078
-3,408
-9% -$425K 0.7% 28
2018
Q1
$4.68M Sell
36,486
-1,923
-5% -$260K 0.88% 19
2017
Q4
$5.36M Buy
38,409
+1,359
+4% +$189K 0.98% 18
2017
Q3
$4.83M Buy
37,050
+4,243
+13% +$562K 1.07% 15
2017
Q2
$4.33M Buy
32,807
+345
+1% +$44K 1.06% 15
2017
Q1
$4.03M Buy
32,462
+1,828
+6% +$218K 1.11% 15
2016
Q4
$3.54M Buy
30,634
+7,223
+31% +$834K 1.18% 14
2016
Q3
$2.77M Sell
23,411
-8,019
-26% -$973K 1.19% 17
2016
Q2
$3.81M Buy
31,430
+2,185
+7% +$248K 1.49% 9
2016
Q1
$3.16M Buy
29,245
+1,096
+4% +$113K 1.37% 11
2015
Q4
$2.89M Buy
+28,149
New +$2.83M 1.33% 14

Other funds holding JNJ

Cetera Investment Advisers's JNJ Position: Q1 2026 in Review

Cetera Investment Advisers increased its Johnson & Johnson (JNJ) stake by 1% in Q1 2026, buying an estimated $2.48M and bringing the position to 1,034,600 shares worth $253M. The position accounts for 0.27% of the portfolio, ranked #65.

Cetera Investment Advisers first reported a position in JNJ in Q4 2015 and has held it in 42 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Cetera Investment Advisers held 1,034,600 shares of Johnson & Johnson worth $253M as of Q1 2026.
  • Cetera Investment Advisers bought 10,644 Johnson & Johnson shares in Q1 2026, an estimated $2.48M.
  • Johnson & Johnson made up 0.27% of Cetera Investment Advisers's portfolio in Q1 2026, its #65 holding.
  • Cetera Investment Advisers first reported a position in Johnson & Johnson in Q4 2015 and has held it in 42 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.